Pacific Biosciences Of California (PACB) Total Debt (QoQ) (2011 - 2023)
Pacific Biosciences Of California (PACB) Total Debt (QoQ) (2011 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Pacific Biosciences Of California | 394.53 Mn | 157.66 Mn | 12.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -99.48% |
| Sep 30, 2023 | -85.09% |
| Jun 30, 2023 | 250.05% |
| Mar 31, 2023 | 5.71% |
| Dec 31, 2018 | 1.91% |
| Sep 30, 2018 | 1.86% |
| Jun 30, 2018 | 1.79% |
| Mar 31, 2018 | 1.74% |
| Dec 31, 2017 | 30.40% |
| Sep 30, 2017 | 0.14% |
| Jun 30, 2017 | -21.51% |
| Mar 31, 2017 | -17.41% |
| Dec 31, 2016 | 1.98% |
| Sep 30, 2016 | 1.92% |
| Jun 30, 2016 | 1.84% |
| Mar 31, 2016 | 1.79% |
| Dec 31, 2015 | 0.95% |
| Sep 30, 2015 | 1.65% |
| Jun 30, 2015 | 1.59% |
| Mar 31, 2015 | 2.49% |